| 000 | 01748 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517121621.0 | ||
| 264 | 0 | _c20170424 | |
| 008 | 201704s 0 0 eng d | ||
| 022 | _a1097-6787 | ||
| 024 | 7 |
_a10.1016/j.jaad.2016.07.047 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWeiss, Doris | |
| 245 | 0 | 0 |
_aUstekinumab treatment in severe atopic dermatitis: Down-regulation of T-helper 2/22 expression. _h[electronic resource] |
| 260 |
_bJournal of the American Academy of Dermatology _cJan 2017 |
||
| 300 |
_a91-97.e3 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aCD4 Lymphocyte Count |
| 650 | 0 | 4 |
_aCytokines _xgenetics |
| 650 | 0 | 4 |
_aDermatitis, Atopic _xdrug therapy |
| 650 | 0 | 4 |
_aDermatologic Agents _xpharmacology |
| 650 | 0 | 4 |
_aDown-Regulation _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGene Expression _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLangerhans Cells _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMast Cells _xdrug effects |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 |
_aT-Lymphocytes, Cytotoxic _xdrug effects |
| 650 | 0 | 4 |
_aTh1 Cells _xmetabolism |
| 650 | 0 | 4 |
_aTh17 Cells _xmetabolism |
| 650 | 0 | 4 |
_aTh2 Cells _xdrug effects |
| 650 | 0 | 4 |
_aUstekinumab _xpharmacokinetics |
| 700 | 1 | _aSchaschinger, Michaela | |
| 700 | 1 | _aRistl, Robin | |
| 700 | 1 | _aGruber, Robert | |
| 700 | 1 | _aKopp, Tamara | |
| 700 | 1 | _aStingl, Georg | |
| 700 | 1 | _aBangert, Christine | |
| 773 | 0 |
_tJournal of the American Academy of Dermatology _gvol. 76 _gno. 1 _gp. 91-97.e3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jaad.2016.07.047 _zAvailable from publisher's website |
| 999 |
_c26519644 _d26519644 |
||